BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12643942)

  • 1. 3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility.
    Black WC; Brideau C; Chan CC; Charleson S; Cromlish W; Gordon R; Grimm EL; Hughes G; Leger S; Li CS; Riendeau D; Thérien M; Wang Z; Xu LJ; Prasit P
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1195-8. PubMed ID: 12643942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,2-Dimethyl-4,5-diaryl-3(2H)furanone derivatives as selective cyclo-oxygenase-2 inhibitors.
    Shin SS; Noh MS; Byun YJ; Choi JK; Kim JY; Lim KM; Ha JY; Kim JK; Lee CH; Chung S
    Bioorg Med Chem Lett; 2001 Jan; 11(2):165-8. PubMed ID: 11206450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors.
    Lau CK; Black WC; Belley M; Chan C; Charleson S; Denis D; Gauthier JY; Gordon R; Guay D; Hamel P; Kargman S; Leblanc Y; Mancini J; Ouellet M; Percival D; Prasit P; Roy P; Skorey K; Tagari P; Vickers P; Wong E
    Adv Exp Med Biol; 1997; 407():73-8. PubMed ID: 9321934
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors.
    Hyup YH; Kwan JK; Kang SH; Noh MS; Ha JY; Kyu JK; Min KM; Hoon CH; Chung S
    Bioorg Med Chem Lett; 2003 Feb; 13(3):413-7. PubMed ID: 12565941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitors.
    Dubé D; Brideau C; Deschênes D; Fortin R; Friesen RW; Gordon R; Girard Y; Riendeau D; Savoie C; Chan CC
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1715-20. PubMed ID: 10397507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives.
    Shin SS; Byun Y; Lim KM; Choi JK; Lee KW; Moh JH; Kim JK; Jeong YS; Kim JY; Choi YH; Koh HJ; Park YH; Oh YI; Noh MS; Chung S
    J Med Chem; 2004 Feb; 47(4):792-804. PubMed ID: 14761182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors.
    Li CS; Black WC; Brideau C; Chan CC; Charleson S; Cromlish WA; Claveau D; Gauthier JY; Gordon R; Greig G; Grimm E; Guay J; Lau CK; Riendeau D; Thérien M; Visco DM; Wong E; Xu L; Prasit P
    Bioorg Med Chem Lett; 1999 Nov; 9(22):3181-6. PubMed ID: 10576684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3-Diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors.
    Black WC; Brideau C; Chan CC; Charleson S; Chauret N; Claveau D; Ethier D; Gordon R; Greig G; Guay J; Hughes G; Jolicoeur P; Leblanc Y; Nicoll-Griffith D; Ouimet N; Riendeau D; Visco D; Wang Z; Xu L; Prasit P
    J Med Chem; 1999 Apr; 42(7):1274-81. PubMed ID: 10197970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors.
    Friesen RW; Brideau C; Chan CC; Charleson S; Deschênes D; Dubé D; Ethier D; Fortin R; Gauthier JY; Girard Y; Gordon R; Greig GM; Riendeau D; Savoie C; Wang Z; Wong E; Visco D; Xu LJ; Young RN
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2777-82. PubMed ID: 9873621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiinflammatory 2-benzyl-4-sulfonyl-4H-isoquinoline-1,3-diones: novel inhibitors of COX-2.
    Lazer ES; Sorcek R; Cywin CL; Thome D; Possanza GJ; Graham AG; Churchill L
    Bioorg Med Chem Lett; 1998 May; 8(10):1181-6. PubMed ID: 9871731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Rowlinson SW; Crews BC; Marnett LJ
    Bioorg Med Chem Lett; 2002 Feb; 12(4):521-4. PubMed ID: 11844663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 3-heteroaryloxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors.
    Lau CK; Brideau C; Chan CC; Charleson S; Cromlish WA; Ethier D; Gauthier JY; Gordon R; Guay J; Kargman S; Li CS; Prasit P; Riendeau D; Thérien M; Visco DM; Xu L
    Bioorg Med Chem Lett; 1999 Nov; 9(22):3187-92. PubMed ID: 10576685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazole analogues of the NSAID indomethacin as selective COX-2 inhibitors.
    Woods KW; McCroskey RW; Michaelides MR; Wada CK; Hulkower KI; Bell RL
    Bioorg Med Chem Lett; 2001 May; 11(10):1325-8. PubMed ID: 11392547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents.
    Khanna IK; Yu Y; Huff RM; Weier RM; Xu X; Koszyk FJ; Collins PW; Cogburn JN; Isakson PC; Koboldt CM; Masferrer JL; Perkins WE; Seibert K; Veenhuizen AW; Yuan J; Yang DC; Zhang YY
    J Med Chem; 2000 Aug; 43(16):3168-85. PubMed ID: 10956225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors.
    Hu W; Guo Z; Chu F; Bai A; Yi X; Cheng G; Li J
    Bioorg Med Chem; 2003 Apr; 11(7):1153-60. PubMed ID: 12628642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building a better aspirin.
    Pennisi E
    Science; 1998 May; 280(5367):1191-2. PubMed ID: 9634399
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
    Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibitors--is there cause for concern?
    Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
    Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
    [No Abstract]   [Full Text] [Related]  

  • 20. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.
    Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Chen J; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
    J Med Chem; 1998 Aug; 41(18):3515-29. PubMed ID: 9719605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.